Jetema, a botulinum toxin and HA filler manufacturer, announced on the 3rd that they are launching a new medical device moisturizer, ‘e.p.t.q. By.derm Intensive Cream MD’.
‘e.p.t.q. By.derm Intensive Cream MD’ is a medical device moisturizer used to protect skin with damaged...
조회수 : 388
e.p.t.q. lidocaine receives approval from Thai FDA
Jetema announced on the 18th that e.p.t.q. lidocaine S100, S300, and S500 have been approved by Thai Food and Drug Administration.
조회수 : 514
e.p.t.q. lidocaine receives approval from Russia
Jetema announced on the 26th that e.p.t.q. lidocaine S100, S300, and S500 have been approved by Russian MOH.
Lidocaine reduces patient’s pain while receiving filler injection.
조회수 : 430
Jetema, successfully held a global webinar for e.p.t.q. filler
Jetema held an online academic forum for three countries on December 12th.
This webinar (web+seminar) was conducted in a non-face-to-face manner, focusing on contents related to epitique fillers for the purpose of expanding the market in Greece, Bulgaria, and Indonesia.
The webinar lecture was co...
조회수 : 525
Jetema, successfully held launching webinar for Brazil
Jetema held an online academic forum for e.p.t.q. filler launching in Brazil on the 17th.
To successfully expand the Brazilian market, forum was composed of contents for local distribution partners and doctors,
and was conducted in the form of webinar (web + seminar).
조회수 : 554
"e.p.t.q. mask" introduced in Korean beauty show "Celeb Beauty2" by hosts Yube Lee and Jimin Kim
e.p.t.q. Skincare RX Hyaluronic acid mask' of Jetema was introduced in
a Korean beauty show 'Celeb Beauty2' as a skincare product of Korean actress, Yube Lee on September 23rd.
조회수 : 315
Jetema concludes a supply contract for filler worth $12 million dollar with a British company
It was announced on 16th that Jetema signed a supply contract for e.p.t.q. filler worth $12million dollar with epitique UK Ltd based in UK·Ireland.
조회수 : 546
Jetema succeeds in product registration for filler in Russia
Jetema has received product registration license for e.p.t.q. filler from Ministry of Health of Russia.
Registered products are e.p.t.q. S100 (0.5ml, 1.0ml, 2.0ml), e.p.t.q. S300 (0.5ml, 1.0ml, 2.0ml), and e.p.t.q. S500 (0.5ml, 1.0ml, 2.0ml).
Jetema is expecting a successful entry into Russian mar...
조회수 : 759
Jetema is launching online channel for epitique mask
In May, Jetema launched an online market for epitique mask, which was previously only available offline at hospitals.
Jetema official said, "we are planning activities using various online platforms along with the opening of an online store,
and we will continue to promote the brand 'epit...
조회수 : 567
Jetema obtains marketing license for filler in Brazil
Jetema announced on 11th that they have obtained a marketing license from Brazil FDA for 'e.p.t.q. lidocaine S500 (HA filler)'.
조회수 : 409
Jetema concluded an exclusive supply contract worth $6.6 million dollar in Russia
Jetema announced that they have concluded an exclusive supply contract of hyaluronic acid filler worth 6.6 million us dollar with a Russian company.
This contract was achieved by the Russian company recognizing excellent safety and efficacy of Jetema's filler, e.p.t.q.
조회수 : 863
Jetema concluded a contract for e.p.t.q. worth 2.7 million dollar to enter middle east market
5 year partnership with Jordan company, "NEDAL"
Jetema announced its exclusive supply contract of e.p.t.q. filler with a Jordan company called 'Nedal'.
The contact is worth $2.5million dollar and its condition is to acquire the license within 6 months and to provide e.p.t.q. fil...
조회수 : 659
Jetema has received a CE marking for epitique filler with lidocaine
- e.p.t.q. lidocaine receives a CE marking, THE TOXIN is waiting for export license… 50% sales increase compared to previous year.
Jetema has announced that e.p.t.q. lidocaine (S100, S300, S500) has received a CE marking on January 21st.
The global hyaluronic acid filler market is about $3...
조회수 : 664
Jetema, hosted a customer satisfaction brand seminar for Ppeum Clinic, one of the largest aesthetic clinics in Korea
Jetema invited general managers from 18 branches to Seoul office and hosted a "Customer Satisfaction Brand Seminar".
This seminar was prepared for training of filler safety experts and marketing training.
Seminar part 1 was comprised of contents regarding trend of aesthetic market, man...
조회수 : 665
Jetema, developed hyaluronic acid with minimzed side effects
Jetema strived to succeed in manufacturing filler with MoD (Degree of Modification) less than 5%, which is lower than Juvederm, the world's #1 product, with MOD of 6~8%
Jetema succeeded in manufacutring filler with significantly less crosslinking agent, resulting in 1.89% MoD.
Strived to develo...